Status
Conditions
Treatments
About
Texture and Color Enhancement Imaging (TXI) is a newly developed image-enhancing endoscopy technology that has show potential in improving detection of colorectal lesions. This multicenter, randomized, tandem trial is aimed at evaluating whether TXI is superior to WLI endoscopy in terms of diagnosis of premalignant lesions.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
patients aged 45-85 years and scheduled for screening colonoscopy who provided written informed consent
Exclusion criteria
Surveillance, diagnostic or therapeutic colonoscopy
Patients with an already known or suspected colorectal tumour
Patients with alarming symptoms and signs, including haematochezia, melena, weight loss or anaemia without specific causes, an abdominal mass and positive digital rectal examination
Pregnant or lactating women
Patients with gastrointestinal tract obstruction
Patients with inflammatory bowel diseases, hereditary CRC syndromes or serrated polyposis syndrome
Patients with abnormal blood coagulation or taking antiplatelets or anticoagulants within 7 days before colonoscopy
Patients with failed cecal intubation
Patients with poor bowel preparation quality that necessitated a second bowel preparation
Patients with a history of colonic resection
Primary purpose
Allocation
Interventional model
Masking
2,964 participants in 4 patient groups
Loading...
Central trial contact
Zhaoshen Li, MD; Yu Bai, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal